Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Net Income (2016 - 2025)

Pediatrix Medical (MD) has disclosed Net Income for 16 consecutive years, with $45.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income rose 61.03% to $45.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $177.3 million, a 275.14% increase, with the full-year FY2025 number at $216.4 million, changed N/A from a year prior.
  • Net Income was $45.6 million for Q4 2025 at Pediatrix Medical, down from $71.7 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $71.7 million in Q3 2025 to a low of -$153.0 million in Q2 2024.
  • A 4-year average of $6.4 million and a median of $6.4 million in 2021 define the central range for Net Income.
  • Peak YoY movement for Net Income: skyrocketed 5869.95% in 2021, then tumbled 179.61% in 2022.
  • Pediatrix Medical's Net Income stood at $7.2 million in 2021, then decreased by 21.77% to $5.7 million in 2022, then soared by 400.34% to $28.3 million in 2024, then surged by 61.03% to $45.6 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Net Income are $45.6 million (Q4 2025), $71.7 million (Q3 2025), and $39.3 million (Q2 2025).